Approval · Notice of Compliance 16553 · 2015
ELLA: Notice of Compliance 16553
Issued January 23, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16553
- Date
- January 23, 2015
- Company
- Laboratoire Hra PharmaChâtillon, --, France
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Emergency contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELLA | 02436329 | Marketed |
Medicinal ingredients
- ULIPRISTAL ACETATE 30 MG per TAB